Literature DB >> 32448591

T-cell and NK-cell lymphomas in the lung.

Zenggang Pan1, Mina L Xu2.   

Abstract

While the lung is frequently involved by systemic lymphoma, primary pulmonary lymphoma accounts for less than 1% of all extranodal ymphomas. In particular, T-cell lymphoma is very rare in the lung, as a primary or secondary lesion. Patients with pulmonary T-cell lymphoma usually present with cough, dyspnea, pain, fever, recurrent infections, and hemoptysis. Typical radiologic features include pulmonary nodules, consolidation, solid pulmonary opacities, cystic changes, hilar adenopathy, and pleural effusions. Patients with these clinical and radiologic findings are frequently presumed to have pneumonia and initially treated with empirical antibiotics. Therefore, CT-guided needle biopsy, bronchoscopic examination, or even wedge biopsy should be considered when clinical symptoms show deterioration despite adequate antibiotic therapy. Precise pathologic diagnosis and molecular characterization are recommended in all cases, following the World Health Organization (WHO) classification. Principles of treatment typically vary with the different histologic types of T-cell lymphoma.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adult T-cell leukemia/lymphoma; Anaplastic large-cell lymphoma; Angioimmunoblastic T-cell lymphoma; Mycosis fungoides; NK/T-cell lymphoma; Peripheral T-cell lymphoma; Pulmonary; Sezary syndrome

Year:  2020        PMID: 32448591     DOI: 10.1053/j.semdp.2020.04.003

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  2 in total

1.  Successful application of extracorporeal membrane oxygenation treatment in the management of severe respiratory failure caused by primary pulmonary lymphoma: A case report.

Authors:  Chao Yu; Lunbing Xv; Xiaochun Peng; Min Shao
Journal:  Medicine (Baltimore)       Date:  2022-01-28       Impact factor: 1.889

2.  Primary pulmonary extranodal NK/T-cell lymphoma: a case report and literature review.

Authors:  Yanli Wang; Zhengxia Wang; Chaojie Wu; Xinyun Zhao; Ningfei Ji; Mao Huang
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.